A VSV-based assay quantifies coronavirus Mpro/3CLpro/Nsp5 main protease activity and chemical inhibition

E Heilmann, F Costacurta, S Geley… - Communications …, 2022 - nature.com
Protease inhibitors are among the most powerful antiviral drugs. However, for SARS-CoV-2
only a small number of protease inhibitors have been identified thus far and there is still a …

合成生物学在基于微生物载体肿瘤疫苗设计中的应用

谭子斌, 梁康, 陈有海 - 合成生物学, 2024 - synbioj.cip.com.cn
合成生物学有望创造具备独特优势的抗肿瘤微生物疫苗, 合成生物学改造的微生物更能适应肿瘤
微环境并在其中富集与增殖, 削弱或者逆转免疫抑制细胞的功能, 并增强肿瘤抗原的呈递 …

Study of key residues in MERS-CoV and SARS-CoV-2 main proteases for resistance against clinically applied inhibitors nirmatrelvir and ensitrelvir

L Krismer, H Schöppe, S Rauch, D Bante, B Sprenger… - npj Viruses, 2024 - nature.com
Abstract The Middle East Respiratory Syndrome Coronavirus (MERS-CoV) is an epidemic,
zoonotically emerging pathogen initially reported in Saudi Arabia in 2012. MERS-CoV has …

Vesicular stomatitis virus as a platform for protease activity measurements

S Rauch, F Costacurta, D von Laer… - Current …, 2024 - Wiley Online Library
Protease inhibitors are among the most powerful antiviral drugs. They have been used
successfully against viruses, such as the human immunodeficiency virus (HIV), hepatitis C …

chronODE: A framework to integrate time-series multi-omics data based on ordinary differential equations combined with machine learning

B Borsari, M Frank, ES Wattenberg, K Xu, SX Liu, X Yu… - bioRxiv, 2023 - biorxiv.org
Most functional genomic studies are conducted in steady-state conditions, therefore
providing a description of molecular processes at a particular moment of cell differentiation …

Development of an RNA virus-based episomal vector with artificial aptazyme for gene silencing

R Komorizono, S Yoshizumi, K Tomonaga - Applied Microbiology and …, 2024 - Springer
RNA virus-based episomal vector (REVec), engineered from Borna disease virus, is an
innovative gene delivery tool that enables sustained gene expression in transduced cells …

Attenuating RNA Viruses with Expanded Genetic Codes to Evoke Adjustable Immune Response in PylRS-tRNA CUA Pyl Transgenic Mice

Z Zheng, X Wu, Y Wang, X Yang, H Chen, Y Shen… - Vaccines, 2023 - mdpi.com
Ribonucleic acid (RNA) viruses pose heavy burdens on public-health systems. Synthetic
biology holds great potential for artificially controlling their replication, a strategy that could …

Applications of synthetic biology in developing microbial-vectored cancer vaccines

Z TAN, K LIANG, Y CHEN - Synthetic Biology Journal, 2024 - synbioj.cip.com.cn
The development of cancer vaccines is confronted with significant challenges. Synthetic
biology emerges as a potent tool for addressing these challenges, due to its ability to modify …

Rational selection of an ideal oncolytic virus to address current limitations in clinical translation

R Basu, CM Moles - International Review of Cell and Molecular Biology, 2023 - Elsevier
Oncolytic virus therapy (OVT) is a promising modality that leverages the propensity of natural
or engineered viruses to selectively replicate in and kill cancer cells. Over the past …

[图书][B] Viral Vectors in Cancer Immunotherapy

FA Vega, P Berraondo, L Galluzzi - 2023 - books.google.com
Viral Vectors in Cancer Immunotherapy, Volume 379 in the International Review of Cell and
Molecular Biology presents the latest on cancer immunotherapy and how it has transformed …